A plain language summary of the BASIS study looking at people living with severe hemophilia A or B with inhibitors and being treated with marstacimab.
Saved in:
| Title: | A plain language summary of the BASIS study looking at people living with severe hemophilia A or B with inhibitors and being treated with marstacimab. |
|---|---|
| Authors: | Matino D; Thrombosis and Atherosclerosis Research Institute, McMaster University, and Department of Medicine, McMaster University, Hamilton, ON, Canada., Acharya SS; Northwell Health, New Hyde Park, NY and Cohen Children's Medical Center, Queens, NY, USA., Taylor CT; Pfizer Inc, Collegeville, PA, USA., Sun P; Pfizer Inc, Cambridge, MA, USA., Agathon D; Pfizer Inc, Paris, France., Raje S; Pfizer Inc, Collegeville, PA, USA., Gould T; Pfizer Inc, New York, NY, USA., Palladino A; Pfizer Inc, Collegeville, PA, USA., Mahlangu J; Department of Molecular Medicine and Haematology, Faculty of Health Sciences, University of the Witwatersrand, National Health Laboratory Service, Johannesburg, South Africa. |
| Source: | Therapeutic advances in hematology [Ther Adv Hematol] 2026 Jun 14; Vol. 17, pp. 20406207261442896. Date of Electronic Publication: 2026 Jun 14 (Print Publication: 2026). |
| Publication Type: | Editorial |
| Journal Info: | Publisher: Sage Country of Publication: England NLM ID: 101549589 Publication Model: eCollection Cited Medium: Print ISSN: 2040-6207 (Print) Linking ISSN: 20406207 NLM ISO Abbreviation: Ther Adv Hematol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42311704 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A plain language summary of the BASIS study looking at people living with severe hemophilia A or B with inhibitors and being treated with marstacimab. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Matino+D%22">Matino D</searchLink>; Thrombosis and Atherosclerosis Research Institute, McMaster University, and Department of Medicine, McMaster University, Hamilton, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Acharya+SS%22">Acharya SS</searchLink>; Northwell Health, New Hyde Park, NY and Cohen Children's Medical Center, Queens, NY, USA.<br /><searchLink fieldCode="AU" term="%22Taylor+CT%22">Taylor CT</searchLink>; Pfizer Inc, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Sun+P%22">Sun P</searchLink>; Pfizer Inc, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Agathon+D%22">Agathon D</searchLink>; Pfizer Inc, Paris, France.<br /><searchLink fieldCode="AU" term="%22Raje+S%22">Raje S</searchLink>; Pfizer Inc, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Gould+T%22">Gould T</searchLink>; Pfizer Inc, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Palladino+A%22">Palladino A</searchLink>; Pfizer Inc, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Mahlangu+J%22">Mahlangu J</searchLink>; Department of Molecular Medicine and Haematology, Faculty of Health Sciences, University of the Witwatersrand, National Health Laboratory Service, Johannesburg, South Africa. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101549589%22">Therapeutic advances in hematology</searchLink> [Ther Adv Hematol] 2026 Jun 14; Vol. 17, pp. 20406207261442896. <i>Date of Electronic Publication: </i>2026 Jun 14 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Editorial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage%22">Sage </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101549589 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2040-6207 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220406207%22">20406207 </searchLink><i>NLM ISO Abbreviation: </i>Ther Adv Hematol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42311704 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1177/20406207261442896 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 20406207261442896 Titles: – TitleFull: A plain language summary of the BASIS study looking at people living with severe hemophilia A or B with inhibitors and being treated with marstacimab. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Matino D – PersonEntity: Name: NameFull: Acharya SS – PersonEntity: Name: NameFull: Taylor CT – PersonEntity: Name: NameFull: Sun P – PersonEntity: Name: NameFull: Agathon D – PersonEntity: Name: NameFull: Raje S – PersonEntity: Name: NameFull: Gould T – PersonEntity: Name: NameFull: Palladino A – PersonEntity: Name: NameFull: Mahlangu J IsPartOfRelationships: – BibEntity: Dates: – D: 14 M: 06 Text: 2026 Jun 14 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 2040-6207 Numbering: – Type: volume Value: 17 Titles: – TitleFull: Therapeutic advances in hematology Type: main |
| ResultId | 1 |